Shanghai Labway Clinical Laboratory Co (SZSE:301060) EV-to-Revenue : 1.84 (As of Jun. 21, 2024)

Shanghai Labway Clinical Laboratory Co EV-to-Revenue Chart

Shanghai Labway Clinical Laboratory Co Annual Data
	Trend	Dec13	Dec14	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-Revenue		Get a 7-Day Free Trial				-	-	7.47	1.81	3.01

Shanghai Labway Clinical Laboratory Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															2.37	2.23	2.42	3.01	2.69

Competitive Comparison of Shanghai Labway Clinical Laboratory Co's EV-to-Revenue

For the Diagnostics & Research subindustry, Shanghai Labway Clinical Laboratory Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Labway Clinical Laboratory Co's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shanghai Labway Clinical Laboratory Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shanghai Labway Clinical Laboratory Co's EV-to-Revenue falls into.

Shanghai Labway Clinical Laboratory Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Shanghai Labway Clinical Laboratory Co's EV-to-Revenue for today is calculated as:

Shanghai Labway Clinical Laboratory Co's current Enterprise Value is ¥3,131 Mil.
Shanghai Labway Clinical Laboratory Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,698 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Labway Clinical Laboratory Co  (SZSE:301060) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Shanghai Labway Clinical Laboratory Co's PS Ratiofor today is calculated as:

Shanghai Labway Clinical Laboratory Co's share price for today is ¥8.60.
Shanghai Labway Clinical Laboratory Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥4.25.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Labway Clinical Laboratory Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shanghai Labway Clinical Laboratory Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Labway Clinical Laboratory Co (SZSE:301060) Business Description